Nick Huerta
@metabolicmastr
Data over dogma
Exercise is a powerful, underused therapy for ischemic cardiomyopathy. This review highlights evidence-based regimens, gaps in current guidelines, and how tech-enabled rehab could boost outcomes and adherence (link.springer.com/article/10.100…). Now in #HREV.
People with heart disease need to exercise, but what should their programming consist of? Our review published today highlights specific evidence based protocols! @MHIM_Baltimore @KoskinaLida @ShiavaxJRaoMD #HeartFailure link.springer.com/article/10.100…
pmc.ncbi.nlm.nih.gov/articles/PMC41… "Social media makes it very easy for people to build a seemingly impressive persona by essentially ‘shouting louder’ than others. Having an opinion on something does not make one an expert. But on Twitter, for example, the ‘top tweet’ on any given subject…
Medical reversal in real-time! Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial | JACC jacc.org/doi/10.1016/j.…
Will be critical to understand these types of studies (acpjournals.org/doi/10.7326/AN…)
Every hospital room should have an erg, especially for individuals with prolonged hospitalization. Effects of Acute Phase Intensive Exercise Training in Patients With Acute Decompensated Heart Failure | JACC: Heart Failure jacc.org/doi/10.1016/j.…
In this SoTA review, we explore recent advances in novel #HCM therapies, the safety & efficacy of #CMI and summarize key American & European guideline recommendations🫀🔗👉🏻doi.org/10.1007/s10741… @othman_leen @KoskinaLida @metabolicmastr @MHIM_Baltimore #CardioTwitter #MedTwitter
HCM is an inherited condition marked by unexplained left ventricular hypertrophy. This SoTA review summarizes traditional therapies & explores the safety and efficacy of emerging cardiac myosin inhibitors like mavacamten & aficamten (link.springer.com/article/10.100…). #HREV @ShiavaxJRaoMD